Lanean...
Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study
BACKGROUND AND AIM: MDM4, a negative regulator of the p53 tumor suppression pathway, has been demonstrated to be overexpressed in a variety of human cancers. Research has revealed that the rs4245739 A>C polymorphism of MDM4 in the 3’-untranslated region makes it a miR-191 target site, leading to...
Gorde:
| Argitaratua izan da: | Asian Pac J Cancer Prev |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
West Asia Organization for Cancer Prevention
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5494227/ https://ncbi.nlm.nih.gov/pubmed/28547953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.4.1133 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|